Position in RVMD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$38,204,077
+$8,904,747 QoQ
Shares Held
392,844
+6.8% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.18437853193635.ToString("F0")%
None 2.8156214680636587.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,191,566,293 across 258 Biotechnology names. RVMD ranks #29 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in RVMD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,204,077 | 392,844 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $29,299,330 | 367,851 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $9,383,990 | 200,942 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,352,027 | 227,019 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,727,556 | 190,259 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,146,096 | 117,652 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,677,604 | 147,246 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,824,763 | 98,551 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,043,509 | 94,431 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,694,499 | 128,818 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,685,525 | 205,402 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,895,664 | 70,866 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,310,818 | 60,518 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $633,444 | 26,593 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $530,900 | 26,922 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $449,925 | 23,085 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $585,173 | 22,939 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $572,188 | 22,733 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $543,293 | 19,749 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $749,762 | 23,622 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $415,397 | 9,054 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $679,086 | 17,153 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $520,430 | 16,485 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||